Pages

Tuesday, November 30, 2010

Multiple Endocrine Diseases in Cats


Multiple endocrine glandular failure is a recognized syndrome in humans, yet it is an uncommonly recognized phenomenon in veterinary medicine. This is a retrospective study characterizing a population of cats from a university veterinary teaching hospital diagnosed with multiple endocrine disorders. The medical records of 15 cats diagnosed with more than one endocrine disease were reviewed. The most common combination of endocrine disorders noted was hyperthyroidism and diabetes mellitus, making up 11 of 15 cases. Two of 15 cases had concurrent diabetes mellitus and hyperadrenocorticism. One other cat had concurrent diabetes mellitus and central diabetes insipidus, while another was diagnosed with hyperthyroidism and hyperparathyroidism.  A majority of the cases were domestic shorthair cats with the mean age of 10.3 years and a mean of 25.7 months elapsing between the diagnosis of the first and second endocrine disorder. The authors’ results suggest the occurrence of multiple endocrine disorders in cats is uncommon. [VT]

Related articles:

More on cat health: Winn Feline Foundation Library

Multiple endocrine glandular failure is a recognized syndrome in humans, yet it is an uncommonly recognized phenomenon in veterinary medicine. This is a retrospective study characterizing a population of cats from a university veterinary teaching hospital diagnosed with multiple endocrine disorders. The medical records of 15 cats diagnosed with more than one endocrine disease were reviewed. The most common combination of endocrine disorders noted was hyperthyroidism and diabetes mellitus, making up 11 of 15 cases. Two of 15 cases had concurrent diabetes mellitus and hyperadrenocorticism. One other cat had concurrent diabetes mellitus and central diabetes insipidus, while another was diagnosed with hyperthyroidism and hyperparathyroidism.  A majority of the cases were domestic shorthair cats with the mean age of 10.3 years and a mean of 25.7 months elapsing between the diagnosis of the first and second endocrine disorder. The authors’ results suggest the occurrence of multiple endocrine disorders in cats is uncommon. [VT]

Related articles:

More on cat health: Winn Feline Foundation Library
Read More


Sunday, November 28, 2010

Garlic 'remedy for hypertension'

Garlic may be useful in addition to medication to treat high blood pressure, a study suggests.

Australian doctors enrolled 50 patients in a trial to see if garlic supplements could help those whose blood pressure was high, despite medication.

Those given four capsules of garlic extract a day had lower blood pressure than those on placebo, they report in scientific journal Maturitas.

The British Heart Foundation said more research was needed.

Garlic has long been though to be good for the heart.

Garlic supplements have previously been shown to lower cholesterol and reduce high blood pressure in those with untreated hypertension.

In the latest study, researchers from the University of Adelaide, Australia, looked at the effects of four capsules a day of a supplement known as aged garlic for 12 weeks.

They found systolic blood pressure was around 10mmHg lower in the group given garlic compared with those given a placebo.

Researcher Karin Ried said: "Garlic supplements have been associated with a blood pressure lowering effect of clinical significance in patients with untreated hypertension.

"Our trial, however, is the first to assess the effect, tolerability and acceptability of aged garlic extract as an additional treatment to existing antihypertensive medication in patients with treated, but uncontrolled, hypertension."

Experts say garlic supplements should only be used after seeking medical advice, as garlic can thin the blood or interact with some medicines.

Ellen Mason, senior cardiac nurse at the British Heart Foundation, said using garlic for medicinal purposes dates back thousands of years, but it is essential that scientific research proves that garlic can help conditions such as raised blood pressure.

She said: "This study demonstrated a slight blood pressure reduction after using aged garlic supplements but it's not significant enough or in a large enough group of people to currently recommend it instead of medication.

"It's a concern that so many people in the UK have poorly controlled blood pressure, with an increased risk of stroke and heart disease as a consequence. So enjoy garlic as part of your diet but don't stop taking your blood pressure medication."
Garlic may be useful in addition to medication to treat high blood pressure, a study suggests.

Australian doctors enrolled 50 patients in a trial to see if garlic supplements could help those whose blood pressure was high, despite medication.

Those given four capsules of garlic extract a day had lower blood pressure than those on placebo, they report in scientific journal Maturitas.

The British Heart Foundation said more research was needed.

Garlic has long been though to be good for the heart.

Garlic supplements have previously been shown to lower cholesterol and reduce high blood pressure in those with untreated hypertension.

In the latest study, researchers from the University of Adelaide, Australia, looked at the effects of four capsules a day of a supplement known as aged garlic for 12 weeks.

They found systolic blood pressure was around 10mmHg lower in the group given garlic compared with those given a placebo.

Researcher Karin Ried said: "Garlic supplements have been associated with a blood pressure lowering effect of clinical significance in patients with untreated hypertension.

"Our trial, however, is the first to assess the effect, tolerability and acceptability of aged garlic extract as an additional treatment to existing antihypertensive medication in patients with treated, but uncontrolled, hypertension."

Experts say garlic supplements should only be used after seeking medical advice, as garlic can thin the blood or interact with some medicines.

Ellen Mason, senior cardiac nurse at the British Heart Foundation, said using garlic for medicinal purposes dates back thousands of years, but it is essential that scientific research proves that garlic can help conditions such as raised blood pressure.

She said: "This study demonstrated a slight blood pressure reduction after using aged garlic supplements but it's not significant enough or in a large enough group of people to currently recommend it instead of medication.

"It's a concern that so many people in the UK have poorly controlled blood pressure, with an increased risk of stroke and heart disease as a consequence. So enjoy garlic as part of your diet but don't stop taking your blood pressure medication."
Read More


Iron in Coronary Artery Plaque Is a Marker of Heart Attack Rick

Newswise — Plaque in a heart artery looks threatening, but cardiologists know that many of these buildups will not erupt, dislodge and block a vessel, causing a heart attack that can be fatal. Some will, however, and the challenge is to figure out atherosclerotic plaque that is dangerous and treat or remove it.

Now, researchers at Mayo Clinic have shown that iron, derived from blood, is much more prevalent in the kind of plaque that is unstable and is thus more likely to promote a myocardial infarction (MI) - heart attack - and possibly sudden death.

The team of researchers has demonstrated through a variety of experiments that iron buildup may be suitable as a marker of risk for a future MI, they reported today at the American Heart Association’s Scientific Sessions 2010 in Chicago.

For example, they have found that Dual Energy Computed Tomography (DECT) and three-dimensional computerized tomography (CT) micro scans can detect excess iron in plaque, thus holding promise that in the future a scanning device might be able to noninvasively detect dangerous plaque formations in patients.

“We know that 70 percent of heart attacks are caused by unstable plaque, so what we really need for our patients is a way to identify the plaque that turns evil and puts them at jeopardy,” says cardiologist Birgit Kantor, M.D., the study’s lead researcher. “The scans we use now just show narrowing of heart arteries from plaque buildup but that doesn’t tell us if the plaque inside those vessels walls is imminently dangerous.”

“We think it is possible, based on these findings, to use iron as a natural marker for risk,” she says. Dr. Kantor predicts that probably 5-10 years will pass before novel diagnostic scanners to identify these plaques become available in cardiology clinics.

Testing iron as a marker in human arteries

Excess iron in atherosclerotic plaque was noticed decades ago, but little research followed up on that observation, Dr. Kantor says. “The hypothesis then was that iron was the poison that created the plaque, but that was never proven and is in fact unlikely.”

Cardiologists now know that plaque can be classified as stable or unstable. Mayo Clinic researchers believe that the amount of iron in the plaque can be seen as a “readout” of prior hemorrhagic, or bleeding, events that put a person at risk for plaque eruption.

In normal heart arteries, small blood vessels known as vasa vasorum bring nutrients to the vessel wall, and when plaque starts to build up inside the artery wall, some of these tiny vessels grow as well to feed them. These vessels can rupture, depositing iron, a component of blood, into the growing plaque. This unstable plaque, which has a large core of dead cells covered by a thin fibrous cap, can eventually rupture, forming a big blood clot that can shut down a heart artery.

“This kind of plaque can bleed and heal, bleed and heal, depositing iron into the buildup,” Dr. Kantor says. “This plaque is at risk of breaking up and causing a heart attack.”

To conduct this study, the researchers used samples from a unique Mayo Clinic biobank of heart arteries collected over time from autopsies of 400 patients who died from a suspected heart attack. Small sections (1–1.5 inches) from the three main coronary arteries of each patient have been preserved.

In this study, pathologists examined 97 artery samples and separated them into stable and unstable groups based on their appearance under a microscope (dead zones and fiber cap). They classified 31 plaques as stable, 24 as “vulnerable,” and 22 as normal and then linked them to patient clinical records to see which patients died from a heart attack.

Then Yu Liu, M.D., Ph.D., the study’s first author, applied a stain to the samples to detect iron content. She found iron content in the unstable plaque group was significantly higher than in the other groups. Iron was absent in normal arteries.

In a third step, the researchers scanned a subset of the artery segments using a benchtop micro-CT scanner, and created 3-D images to look for iron deposits in plaque. The CT could identify iron in plaque without the need for staining. “There was a high correlation between the vulnerability of the plaque and the quantity of iron in it,” says Dr. Kantor.

Still, non-invasive imaging for plaque does not yet have the necessary resolution to differentiate high risk from low risk plaque in patients, she says, and so the research team is testing other imaging modalities such as photon counting that can overcome these barriers.
Newswise — Plaque in a heart artery looks threatening, but cardiologists know that many of these buildups will not erupt, dislodge and block a vessel, causing a heart attack that can be fatal. Some will, however, and the challenge is to figure out atherosclerotic plaque that is dangerous and treat or remove it.

Now, researchers at Mayo Clinic have shown that iron, derived from blood, is much more prevalent in the kind of plaque that is unstable and is thus more likely to promote a myocardial infarction (MI) - heart attack - and possibly sudden death.

The team of researchers has demonstrated through a variety of experiments that iron buildup may be suitable as a marker of risk for a future MI, they reported today at the American Heart Association’s Scientific Sessions 2010 in Chicago.

For example, they have found that Dual Energy Computed Tomography (DECT) and three-dimensional computerized tomography (CT) micro scans can detect excess iron in plaque, thus holding promise that in the future a scanning device might be able to noninvasively detect dangerous plaque formations in patients.

“We know that 70 percent of heart attacks are caused by unstable plaque, so what we really need for our patients is a way to identify the plaque that turns evil and puts them at jeopardy,” says cardiologist Birgit Kantor, M.D., the study’s lead researcher. “The scans we use now just show narrowing of heart arteries from plaque buildup but that doesn’t tell us if the plaque inside those vessels walls is imminently dangerous.”

“We think it is possible, based on these findings, to use iron as a natural marker for risk,” she says. Dr. Kantor predicts that probably 5-10 years will pass before novel diagnostic scanners to identify these plaques become available in cardiology clinics.

Testing iron as a marker in human arteries

Excess iron in atherosclerotic plaque was noticed decades ago, but little research followed up on that observation, Dr. Kantor says. “The hypothesis then was that iron was the poison that created the plaque, but that was never proven and is in fact unlikely.”

Cardiologists now know that plaque can be classified as stable or unstable. Mayo Clinic researchers believe that the amount of iron in the plaque can be seen as a “readout” of prior hemorrhagic, or bleeding, events that put a person at risk for plaque eruption.

In normal heart arteries, small blood vessels known as vasa vasorum bring nutrients to the vessel wall, and when plaque starts to build up inside the artery wall, some of these tiny vessels grow as well to feed them. These vessels can rupture, depositing iron, a component of blood, into the growing plaque. This unstable plaque, which has a large core of dead cells covered by a thin fibrous cap, can eventually rupture, forming a big blood clot that can shut down a heart artery.

“This kind of plaque can bleed and heal, bleed and heal, depositing iron into the buildup,” Dr. Kantor says. “This plaque is at risk of breaking up and causing a heart attack.”

To conduct this study, the researchers used samples from a unique Mayo Clinic biobank of heart arteries collected over time from autopsies of 400 patients who died from a suspected heart attack. Small sections (1–1.5 inches) from the three main coronary arteries of each patient have been preserved.

In this study, pathologists examined 97 artery samples and separated them into stable and unstable groups based on their appearance under a microscope (dead zones and fiber cap). They classified 31 plaques as stable, 24 as “vulnerable,” and 22 as normal and then linked them to patient clinical records to see which patients died from a heart attack.

Then Yu Liu, M.D., Ph.D., the study’s first author, applied a stain to the samples to detect iron content. She found iron content in the unstable plaque group was significantly higher than in the other groups. Iron was absent in normal arteries.

In a third step, the researchers scanned a subset of the artery segments using a benchtop micro-CT scanner, and created 3-D images to look for iron deposits in plaque. The CT could identify iron in plaque without the need for staining. “There was a high correlation between the vulnerability of the plaque and the quantity of iron in it,” says Dr. Kantor.

Still, non-invasive imaging for plaque does not yet have the necessary resolution to differentiate high risk from low risk plaque in patients, she says, and so the research team is testing other imaging modalities such as photon counting that can overcome these barriers.
Read More


Vitamin C: A potential life-saving treatment for sepsis

Physicians caring for patients with sepsis may soon have a new safe and cost-effective treatment for this life-threatening illness. Research led by Dr. Karel Tyml and his colleagues at The University of Western Ontario and Lawson Health Research Institute have found that vitamin C can not only prevent the onset of sepsis, but can reverse the disease.

Sepsis is caused by a bacterial infection that can begin anywhere in your body. Your immune system goes into overdrive, overwhelming normal processes in your blood. The result is that small blood clots form, blocking blood flow to vital organs. This can lead to organ failure. Babies, the elderly and those with weakened immune systems are most likely to get sepsis. But even healthy people can become deathly ill from the disease.

According to Dr. Tyml, a professor at Western's Schulich School of Medicine & Dentistry, patients with severe sepsis have a high mortality rate, nearly 40 percent, because there is no effective treatment.

"There are many facets to sepsis, but the one we have focused on for the past 10 years is the plugging of capillaries," says Dr. Tyml. Plugged capillaries prevent oxygenation and the supply of life-supporting materials to your organ tissue and stop the removal of metabolic waste product. Plugged capillaries are seen in organs of septic patients. These organs may eventually fail, leading to multiple organ failure and death. Dr. Tyml's lab was the first to discover this plugging by using intravital microscopy, a technique Dr. Tyml pioneered in Canada.

According to Dr. Tyml's most recent publication, oxidative stress and the activated blood clotting pathway are the major factors responsible for the capillary plugging in sepsis. Through his research, Dr. Tyml has discovered that a single bolus of vitamin C injected early at the time of induction of sepsis, prevents capillary plugging. He has also found that a delayed bolus injection of vitamin C can reverse plugging by restoring blood flow in previously plugged capillaries.

"Our research in mice with sepsis has found that early as well as delayed injections of vitamin C improves chance of survival significantly," explains Dr. Tyml. "Furthermore, the beneficial effect of a single bolus injection of vitamin C is long lasting and prevents capillary plugging for up to 24 hours post-injection."

Dr. Tyml and his colleagues are eager to find appropriate support to move this research from the bench to the bedside to see if these findings translate to patients with sepsis.

The potential benefit of this treatment is substantial. "Vitamin C is cheap and safe. Previous studies have shown that it can be injected intravenously into patients with no side effects," says Dr. Tyml. "It has the potential to significantly improve the outcome of sepsis patients world-wide. This could be especially beneficially in developing countries where sepsis is more common and expensive treatments are not affordable."
Physicians caring for patients with sepsis may soon have a new safe and cost-effective treatment for this life-threatening illness. Research led by Dr. Karel Tyml and his colleagues at The University of Western Ontario and Lawson Health Research Institute have found that vitamin C can not only prevent the onset of sepsis, but can reverse the disease.

Sepsis is caused by a bacterial infection that can begin anywhere in your body. Your immune system goes into overdrive, overwhelming normal processes in your blood. The result is that small blood clots form, blocking blood flow to vital organs. This can lead to organ failure. Babies, the elderly and those with weakened immune systems are most likely to get sepsis. But even healthy people can become deathly ill from the disease.

According to Dr. Tyml, a professor at Western's Schulich School of Medicine & Dentistry, patients with severe sepsis have a high mortality rate, nearly 40 percent, because there is no effective treatment.

"There are many facets to sepsis, but the one we have focused on for the past 10 years is the plugging of capillaries," says Dr. Tyml. Plugged capillaries prevent oxygenation and the supply of life-supporting materials to your organ tissue and stop the removal of metabolic waste product. Plugged capillaries are seen in organs of septic patients. These organs may eventually fail, leading to multiple organ failure and death. Dr. Tyml's lab was the first to discover this plugging by using intravital microscopy, a technique Dr. Tyml pioneered in Canada.

According to Dr. Tyml's most recent publication, oxidative stress and the activated blood clotting pathway are the major factors responsible for the capillary plugging in sepsis. Through his research, Dr. Tyml has discovered that a single bolus of vitamin C injected early at the time of induction of sepsis, prevents capillary plugging. He has also found that a delayed bolus injection of vitamin C can reverse plugging by restoring blood flow in previously plugged capillaries.

"Our research in mice with sepsis has found that early as well as delayed injections of vitamin C improves chance of survival significantly," explains Dr. Tyml. "Furthermore, the beneficial effect of a single bolus injection of vitamin C is long lasting and prevents capillary plugging for up to 24 hours post-injection."

Dr. Tyml and his colleagues are eager to find appropriate support to move this research from the bench to the bedside to see if these findings translate to patients with sepsis.

The potential benefit of this treatment is substantial. "Vitamin C is cheap and safe. Previous studies have shown that it can be injected intravenously into patients with no side effects," says Dr. Tyml. "It has the potential to significantly improve the outcome of sepsis patients world-wide. This could be especially beneficially in developing countries where sepsis is more common and expensive treatments are not affordable."
Read More


Tuesday, November 23, 2010

Feline Hyperthyroidism and Kidney Disease

Williams T, Elliott J, Syme H: Association of iatrogenic hypothyroidism with azotemia and reduced survival time in cats treated for hyperthyroidism, J Vet Intern Med 24:1086, 2010.

Within 6 months of treatment of hyperthyroidism, 17-49% of cats develop azotemia. Treatment to restore euthyroidism in cats results in a decrease in renal glomerular filtration rate (GFR) which can lead to the development of azotemia if underlying chronic renal disease (CRD) is present. Antithyroid treatment could lead to iatrogenic hypothyroidism and hypothyroidism has been correlated with reduced GFR. The authors performed two retrospective studies. The first study was of 12 hyperthyroid cats treated with radioiodine and documented as euthyroid after treatment where changes were assessed in plasma thyroid stimulating hormone (TSH) concentration over a 6-month follow-up period. The second study was of 75 hyperthyroid cats, documented as euthyroid, that were monitored 6 months after starting treatment to identify the relationship between thyroid status and the development of azotemia. Plasma TSH concentrations were not suppressed in 7 of 8 cats with hypothyroidism 3 months after radioiodine treatment. The study concluded that cats with iatrogenic hypothyroidism were more likely to develop azotemia within 6 months after treatment for hyperthyroidism than cats defined as euthyroid. Hypothyroid cats with azotemia had shorter survival times than non-azotemic cats.  There was no difference in survival times of euthyroid cats with or without azotemia.  [VT]

Related articles:
Williams TL, Peak KJ, Brodbelt D et al: Survival and the development of azotemia after treatment of hyperthyroid cats, J Vet Intern Med 24:863, 2010.

More on cat health: Winn Feline Foundation Library
Join us on Facebook
Follow us on Twitter
Williams T, Elliott J, Syme H: Association of iatrogenic hypothyroidism with azotemia and reduced survival time in cats treated for hyperthyroidism, J Vet Intern Med 24:1086, 2010.

Within 6 months of treatment of hyperthyroidism, 17-49% of cats develop azotemia. Treatment to restore euthyroidism in cats results in a decrease in renal glomerular filtration rate (GFR) which can lead to the development of azotemia if underlying chronic renal disease (CRD) is present. Antithyroid treatment could lead to iatrogenic hypothyroidism and hypothyroidism has been correlated with reduced GFR. The authors performed two retrospective studies. The first study was of 12 hyperthyroid cats treated with radioiodine and documented as euthyroid after treatment where changes were assessed in plasma thyroid stimulating hormone (TSH) concentration over a 6-month follow-up period. The second study was of 75 hyperthyroid cats, documented as euthyroid, that were monitored 6 months after starting treatment to identify the relationship between thyroid status and the development of azotemia. Plasma TSH concentrations were not suppressed in 7 of 8 cats with hypothyroidism 3 months after radioiodine treatment. The study concluded that cats with iatrogenic hypothyroidism were more likely to develop azotemia within 6 months after treatment for hyperthyroidism than cats defined as euthyroid. Hypothyroid cats with azotemia had shorter survival times than non-azotemic cats.  There was no difference in survival times of euthyroid cats with or without azotemia.  [VT]

Related articles:
Williams TL, Peak KJ, Brodbelt D et al: Survival and the development of azotemia after treatment of hyperthyroid cats, J Vet Intern Med 24:863, 2010.

More on cat health: Winn Feline Foundation Library
Join us on Facebook
Follow us on Twitter
Read More


Sunday, November 21, 2010

Alcohol Damages Much More Than The Liver

Newswise — Alcohol does much more harm to the body than just damaging the liver. Drinking also can weaken the immune system, slow healing, impair bone formation, increase the risk of HIV transmission and hinder recovery from burns, trauma, bleeding and surgery.

Researchers will release the latest findings on such negative effects of alcohol during a meeting Nov. 19 of the Alcohol and Immunology Research Interest Group at Loyola University Medical Center.

At Loyola, about 50 faculty members, technicians, post-doctoral fellows and students are conducting alcohol research. Studies at Loyola and other centers could lead to therapies to boost the immune system or otherwise minimize the effects of alcohol, said Elizabeth J. Kovacs, PhD, director of Loyola's Alcohol Research Program and associate director of Loyola's Burn & Shock Trauma Institute.

"Of course, the best way to prevent the damaging effects of alcohol is to not drink in the first place," Kovacs said. "But it is very difficult to get people to do this."

Sessions at the conference include Alcohol and Infection, Alcohol and Oxidative Stress and Alcohol and Organ Inflammation. Findings will be presented by researchers from centers around the country, including Loyola, Cleveland Clinic, University of Iowa, University of Colorado, University of Massachusetts, Mississippi State University, Chicago State University and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).

The conference is supported by Loyola's Alcohol Research Program and Department of Surgery at Loyola University Chicago Stritch School of Medicine, the Society for Leukocyte Biology and the NIAAA.
Newswise — Alcohol does much more harm to the body than just damaging the liver. Drinking also can weaken the immune system, slow healing, impair bone formation, increase the risk of HIV transmission and hinder recovery from burns, trauma, bleeding and surgery.

Researchers will release the latest findings on such negative effects of alcohol during a meeting Nov. 19 of the Alcohol and Immunology Research Interest Group at Loyola University Medical Center.

At Loyola, about 50 faculty members, technicians, post-doctoral fellows and students are conducting alcohol research. Studies at Loyola and other centers could lead to therapies to boost the immune system or otherwise minimize the effects of alcohol, said Elizabeth J. Kovacs, PhD, director of Loyola's Alcohol Research Program and associate director of Loyola's Burn & Shock Trauma Institute.

"Of course, the best way to prevent the damaging effects of alcohol is to not drink in the first place," Kovacs said. "But it is very difficult to get people to do this."

Sessions at the conference include Alcohol and Infection, Alcohol and Oxidative Stress and Alcohol and Organ Inflammation. Findings will be presented by researchers from centers around the country, including Loyola, Cleveland Clinic, University of Iowa, University of Colorado, University of Massachusetts, Mississippi State University, Chicago State University and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).

The conference is supported by Loyola's Alcohol Research Program and Department of Surgery at Loyola University Chicago Stritch School of Medicine, the Society for Leukocyte Biology and the NIAAA.
Read More


Exercise May Reduce Rick of Edometrial Cancer

Newswise — Women who exercise for 150 minutes a week or more may see a reduced risk of endometrial cancer, despite whether or not they are overweight, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.

“This study is consistent with other studies that strongly support the association between physical activity and lower risk of endometrial cancer,” said Hannah Arem, a doctoral student at Yale School of Public Health.

Arem and colleagues examined data collected from a case-control study led by Herbert Yu, M.D., M.Sc., Ph.D., associate professor at Yale School of Public Health. The study included 668 women with endometrial cancer and compared them to 665 age-matched control women.

Those who exercised for 150 minutes a week or more had a 34 percent reduced risk of endometrial cancer compared with those women who were inactive.

This association was more pronounced among active women with a body mass index (BMI) less than 25, or underweight women, where the reduction in risk was 73 percent compared with inactive women with a BMI more than 25, or what is commonly considered overweight.

Although BMI showed a strong association with endometrial cancer, even women who were overweight, but still active, had a 52 percent lower risk.

“Clearly, programs should be in place to increase the level of physical activity in women,” said Arem.
Newswise — Women who exercise for 150 minutes a week or more may see a reduced risk of endometrial cancer, despite whether or not they are overweight, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.

“This study is consistent with other studies that strongly support the association between physical activity and lower risk of endometrial cancer,” said Hannah Arem, a doctoral student at Yale School of Public Health.

Arem and colleagues examined data collected from a case-control study led by Herbert Yu, M.D., M.Sc., Ph.D., associate professor at Yale School of Public Health. The study included 668 women with endometrial cancer and compared them to 665 age-matched control women.

Those who exercised for 150 minutes a week or more had a 34 percent reduced risk of endometrial cancer compared with those women who were inactive.

This association was more pronounced among active women with a body mass index (BMI) less than 25, or underweight women, where the reduction in risk was 73 percent compared with inactive women with a BMI more than 25, or what is commonly considered overweight.

Although BMI showed a strong association with endometrial cancer, even women who were overweight, but still active, had a 52 percent lower risk.

“Clearly, programs should be in place to increase the level of physical activity in women,” said Arem.
Read More